Status:
RECRUITING
Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Drug-drug Interactions
Geriatric Disease
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Polypharmacy in the older adults is common and promotes the risk of drug interactions. The hypothesis evoked is that a virtual platform with artificial intelligence applied to the health, and in parti...
Detailed Description
The French 2018-2022 National Health Strategy plan aims to reduce the proportion of potentially harmful medication use. One particular challenge is the phenomenon of polypharmacy and inappropriate med...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male or female age aged more than 65 years
- Hospitalization in geriatric department at Bordeaux University Hospital or Libourne Hospital
- Initial drug prescription with at least 2 active pharmaceutical ingredients
- Affiliation to French social security
- Written informed consent signed by participant and investigator
- Exclusion criteria:
- Adults protected by law
- Subject included in a clinical trial with an experimental treatment
- Subject during exclusion period relative to another trial
Exclusion
Key Trial Info
Start Date :
October 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 5 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04710615
Start Date
October 5 2021
End Date
May 5 2024
Last Update
February 2 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux, Hôpital Pellegrin
Bordeaux, France, 33000
2
CHU de Bordeaux
Bordeaux, France, 33000
3
Centre Hospitalier de Libourne - Pôle Gériatrie
Libourne, France, 33500
4
CHU de Bordeaux, Hôpital Xavier Arnozan
Pessac, France, 33400